成都力思特制药股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
10
NMPA:10
Drug Approvals
Sultamicillin Tosilate Tablets
- Product Name
- 托西酸舒他西林片
- Approval Number
- 国药准字H20067917
- Approval Date
- Apr 30, 2021
NMPA
Sultamicillin Tosilate Tablets
- Product Name
- 托西酸舒他西林片
- Approval Number
- 国药准字H20059121
- Approval Date
- Apr 30, 2021
NMPA
Ampicillin and Probenecid Capsules
- Product Name
- 氨苄西林丙磺舒胶囊
- Approval Number
- 国药准字H20057151
- Approval Date
- Apr 30, 2021
NMPA
Phenoxymethylpenicillin Potassium Granules
- Product Name
- 力特尔新
- Approval Number
- 国药准字H20030726
- Approval Date
- Apr 30, 2021
NMPA
Sultamicillin Tosilate Tablets
- Product Name
- 托西酸舒他西林片
- Approval Number
- 国药准字H20067918
- Approval Date
- Apr 30, 2021
NMPA
Lomefloxacin Aspartate Injection
- Product Name
- 门冬氨酸洛美沙星注射液
- Approval Number
- 国药准字H20057916
- Approval Date
- Feb 3, 2021
NMPA
Clindamycin Phosphate Injection
- Product Name
- 克林霉素磷酸酯注射液
- Approval Number
- 国药准字H20103727
- Approval Date
- Jan 25, 2021
NMPA
Clindamycin Phosphate Injection
- Product Name
- 克林霉素磷酸酯注射液
- Approval Number
- 国药准字H20058180
- Approval Date
- Dec 18, 2020
NMPA
Ampicillin and Probenecid Dispersible Tablets
- Product Name
- 氨苄西林丙磺舒分散片
- Approval Number
- 国药准字H20060816
- Approval Date
- Dec 31, 2015
NMPA
Clinical Trials
No trials found
News
No news found